| Recruitment status | Suspended |
| Unique ID issued by UMIN | UMIN000045346 |
| Receipt No. | R000047554 |
| Scientific Title | Study on cancer patient parameters. |
| Date of disclosure of the study information | 2021/09/02 |
| Last modified on | 2021/09/02 (Ver. 1) |
| Basic information | ||
| Public title | KUMAMON cancer registry | |
| Acronym | KUMAMON cancer registry | |
| Scientific Title | Study on cancer patient parameters. | |
| Scientific Title:Acronym | Study on cancer patient parameters. | |
| Region |
|
|
| Condition | ||
| Condition | malignant disease | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The progress in cancer treatment has been remarkable, and in addition to surgical treatment, chemotherapy with various targeted drugs and new radiation therapy have been developed, and the survival rate of cancer patients has been greatly improved. Along with this, there are some reports that the onset of cardiovascular disease affects the prognosis of cancer patients. |
| Basic objectives2 | Others |
| Basic objectives -Others | Currently, studies are underway to identify new biomarkers for the pathogenesis of cardiovascular disease such as arteriosclerosis and coronary artery disease in cancer patients. This time, in this study, diagnosis of various cardiovascular diseases (ischemic heart disease/peripheral artery disease, cardiomyopathy, heart failure, arrhythmia, valvular heart disease, aortic aneurysm, aortic dissection, venous thrombosis), determination of severity and therapeutic effect, We will search for biomarkers that can be prognostic and examine their usefulness. |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | all cause mortality |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Cancer patients who are registered in the Cancer Registration Section of our hospital. | |||
| Key exclusion criteria | none | |||
| Target sample size | 35000 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kumamoto University | ||||||
| Division name | Cardiovascular Medicine | ||||||
| Zip code | 860-8556 | ||||||
| Address | 1-1-1, Honjo, Kumamoto | ||||||
| TEL | 096-373-5175 | ||||||
| sueta-d@kumamoto-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kumamoto University | ||||||
| Division name | Cardiovascular Medicine | ||||||
| Zip code | 860-8556 | ||||||
| Address | 1-1-1, Honjo, Kumamoto | ||||||
| TEL | 096-373-5175 | ||||||
| Homepage URL | |||||||
| sueta-d@kumamoto-u.ac.jp | |||||||
| Sponsor | |
| Institute | Kumamoto University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | self-funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Kumamoto University |
| Address | 1-1-1, Honjo, Kumamoto |
| Tel | 096-373-5175 |
| sueta-d@kumamoto-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Suspended | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | observation study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047554 |